ABI Sees Significant Growth Opportunity In $5 Billion Research-Validation Market | GenomeWeb
This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
Looking for opportunities beyond traditional genomics and proteomics applications, an Applied Biosystems official said this week that the firm is directing investments toward a rapidly growing research-validation market, which he claims offers a greater market potential than the early-stage research markets in which the firm has traditionally participated.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.